Mirtazapine to alleviate severe breathlessness in patients with COPD or interstitial lung diseases (BETTER-B): an international, multicentre, double-blind, randomised, placebo-controlled, phase 3 mixed-method trial

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00187-5/fulltext?dgcid=hubspot_update_feature_updatealerts_lanres&utm_campaign=update-lanres&utm_medium=email&_hsenc=p2ANqtz-9DF-_bh9W9KGxbxwGcTOmCE4iwEtfEiF3eE37ggghIvLLeLzyCcCZwXHJ6OGSi1pUCBqjU3TjXlgHlWebYWvB7axewvw&_hsmi=329043091&utm_content=329004148&utm_source=hs_email